Advertisement

Advertisement

ETON Stock Latest News

Eton Pharmaceuticals Relaunches HEMANGEOL With Exclusive Distribution

Company AnnouncementsEton Pharmaceuticals Relaunches HEMANGEOL With Exclusive Distribution

Eton Pharmaceuticals announces relaunch of Hemangeol

PremiumThe Fly

Eton Pharmaceuticals announces relaunch of Hemangeol

13h ago

Eton Starts Pilot Trial of ET-700 for Wilson Disease

PremiumCompany Announcements

Eton Starts Pilot Trial of ET-700 for Wilson Disease

5d ago

Eton Pharmaceuticals says first patient dosed in study of ET-700

PremiumThe Fly

Eton Pharmaceuticals says first patient dosed in study of ET-700

5d ago

Eton Pharmaceuticals Announces New Chief Financial Officer Appointment

PremiumCompany Announcements

Eton Pharmaceuticals Announces New Chief Financial Officer Appointment

16d ago

Eton Pharmaceuticals appoints Judith Matthews as CFO

PremiumThe FlyEton Pharmaceuticals appoints Judith Matthews as CFO

16d ago

Eton Pharmaceuticals Amends Credit Agreement, Eases Debt Terms

Company Announcements

Eton Pharmaceuticals Amends Credit Agreement, Eases Debt Terms

16d ago

Eton Pharmaceuticals Maps Aggressive Rare-Disease Growth Path

Company Announcements

Eton Pharmaceuticals Maps Aggressive Rare-Disease Growth Path

1M ago

Eton Pharmaceuticals price target raised to $52 from $37 at H.C. Wainwright

PremiumThe Fly

Eton Pharmaceuticals price target raised to $52 from $37 at H.C. Wainwright

1M ago

Eton Pharmaceuticals: Expanding Rare-Disease Portfolio Underpins Attainable Growth Targets and Upside to $52 Price Target

PremiumRatings

Eton Pharmaceuticals: Expanding Rare-Disease Portfolio Underpins Attainable Growth Targets and Upside to $52 Price Target

1M ago

Eton Pharmaceuticals price target raised to $35 from $30 at Craig-Hallum

PremiumThe Fly

Eton Pharmaceuticals price target raised to $35 from $30 at Craig-Hallum

1M ago

Eton Pharmaceuticals price target raised to $31 from $26 at B. Riley

PremiumThe Fly

Eton Pharmaceuticals price target raised to $31 from $26 at B. Riley

1M ago

Eton Pharmaceuticals reports Q4 EPS 5c vs. (2c) last year

PremiumThe FlyEton Pharmaceuticals reports Q4 EPS 5c vs. (2c) last year

1M ago

Eton Pharmaceuticals sees FY26 revenue at least $110M, consensus $105.25M

The Fly

Eton Pharmaceuticals sees FY26 revenue at least $110M, consensus $105.25M

1M ago

Is ETON a Buy, Before Earnings?

Pre-Earnings

Is ETON a Buy, Before Earnings?

2M ago

Eton Pharmaceuticals participates in a conference call with Craig-Hallum

PremiumThe Fly

Eton Pharmaceuticals participates in a conference call with Craig-Hallum

2M ago

Eton Pharmaceuticals price target raised to $30 from $29 at Craig-Hallum

PremiumThe Fly

Eton Pharmaceuticals price target raised to $30 from $29 at Craig-Hallum

2M ago

Eton Pharmaceuticals Acquires U.S. Rights to HEMANGEOL

PremiumCompany Announcements

Eton Pharmaceuticals Acquires U.S. Rights to HEMANGEOL

2M ago

Eton in-licenses U.S. commercialization rights to HEMANGEOL from Pierre Fabre

PremiumThe Fly

Eton in-licenses U.S. commercialization rights to HEMANGEOL from Pierre Fabre

2M ago

Eton Pharmaceuticals price target raised to $37 from $35 at H.C. Wainwright

PremiumThe FlyEton Pharmaceuticals price target raised to $37 from $35 at H.C. Wainwright

2M ago

Eton Pharmaceuticals Wins FDA Approval for DESMODA Therapy

Company Announcements

Eton Pharmaceuticals Wins FDA Approval for DESMODA Therapy

2M ago

Eton Pharmaceuticals trading resumes

The Fly

Eton Pharmaceuticals trading resumes

2M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >